Directed evolution expands CRISPR–Cas12a genome-editing capacity
Nucleic Acids Research · 08.07.2025 · 53 (13)
DOI: 10.1093/nar/gkaf649 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 16.07.2025. Verfasst von Enbo Ma und 8 weiteren Autor:innen. Beteiligte Einrichtung: Innovative Genomics Institute, University of California, Berkeley, Berkeley, CA 94720, United States. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Gene Editing, CRISPR-Associated Proteins, Directed Molecular Evolution. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Life Sciences Research Foundation, NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
CRISPR–Cas12a enzymes are versatile RNA-guided genome-editing tools with applications encompassing viral diagnosis, agriculture, and human therapeutics. However, their dependence on a 5′-TTTV-3′ protospacer adjacent motif (PAM) next to DNA target sequences restricts Cas12a’s gene targeting capability to only ∼1% of a typical genome. To mitigate this constraint, we used a bacterial-based directed evolution assay combined with rational engineering to identify variants of Lachnospiraceae bacterium Cas12a with expanded PAM recognition. The resulting Cas12a variants use a range of noncanonical PAMs while retaining recognition of the canonical 5′-TTTV-3′ PAM. In particular, biochemical and cell-based assays show that the variant Flex-Cas12a utilizes 5′-NYHV-3′ PAMs that expand DNA recognition sites to ∼25% of the human genome. With enhanced targeting versatility, Flex-Cas12a unlocks access to previously inaccessible genomic loci, providing new opportunities for both therapeutic and agricultural genome engineering.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Innovative Genomics Institute, University of California, Berkeley, Berkeley, CA 94720, United States.
- Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA 94720, United States.
- Howard Hughes Medical Institute, University of California, Berkeley, Berkeley, CA 94720, United States.
- California Institute for Quantitative Biosciences (QB3), University of California, Berkeley, Berkeley, CA 94720, United States.
- Molecular Biophysics and Integrated Bioimaging Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, United States.
- Li Ka Shing Center for Genomic Engineering, University of California, Berkeley, Berkeley, CA 94720, United States.
ORCID-Profile: Enbo Ma, Kai Chen, Honglue Shi, Jennifer A Doudna
Förderung
- Life Sciences Research Foundation
- NIH HHS
- NHLBI NIH HHS
- DOE
- Mr Li Ka Shing
- Howard Hughes Medical Institute
- NIAID NIH HHS
- Emerson Collective
Zitieren
APA
Ma, E., Chen, K., Shi, H., Wasko, K. M., Esain-Garcia, I., Trinidad, M. I., Zhou, K., Ye, J., & Doudna, J. A. (2025). Directed evolution expands CRISPR–Cas12a genome-editing capacity. Nucleic Acids Research, 53(13). https://doi.org/10.1093/nar/gkaf649
Vancouver
Ma E, Chen K, Shi H, Wasko KM, Esain-Garcia I, Trinidad MI, et al. Directed evolution expands CRISPR–Cas12a genome-editing capacity. Nucleic Acids Research. 2025;53(13). doi:10.1093/nar/gkaf649
BibTeX
@article{Ma2025,
author = {Ma, Enbo and Chen, Kai and Shi, Honglue and Wasko, Kevin M and Esain-Garcia, Isabel and Trinidad, Marena I and Zhou, Kaihong and Ye, Jinjuan and Doudna, Jennifer A},
title = {Directed evolution expands CRISPR–Cas12a genome-editing capacity},
journal = {Nucleic Acids Research},
year = {2025},
volume = {53},
number = {13},
doi = {10.1093/nar/gkaf649}
}
EUVIMED